The price of Fondaparinux sodium injection can vary depending on factors such as dosage, quantity, and the pharmacy or healthcare provider administering it. On average, a 2.5 mg/0.5 mL vial may cost approximately $100-$200. A 5 mg/0.4 mL vial could range from $150-$300, and a 7.5 mg/0.6 mL vial might be priced between $180-$350 [1]. These figures are estimates, and actual costs may differ.
Why is Fondaparinux Sodium Injection So Expensive?
The cost of Fondaparinux sodium injection is influenced by several elements inherent in pharmaceutical pricing. These include the significant research and development expenses associated with bringing a drug to market, the complex manufacturing processes involved, and the ongoing costs of clinical trials and regulatory compliance. Furthermore, market demand and patent exclusivity can also play a role in price determination.
Can Generic Versions of Fondaparinux Be Cheaper?
Generic versions of Fondaparinux sodium injection are available, and they typically offer a lower price point compared to the brand-name product. The introduction of generics usually follows the expiry of patents or other forms of market exclusivity held by the original manufacturer. This increased competition often drives down prices for consumers and healthcare systems.
When Does the Patent for Fondaparinux Expire?
The patent landscape for Fondaparinux is complex. While the original patent for the drug has expired, leading to the availability of generic versions, there may be other patents related to specific formulations, manufacturing processes, or methods of use that could still be in effect [2]. Information on patent expiry dates for specific drug products can be found on specialized databases, such as DrugPatentWatch.com [2].
What are the Alternatives to Fondaparinux Sodium Injection?
Alternatives to Fondaparinux sodium injection include other anticoagulant medications used to prevent and treat blood clots. These can include unfractionated heparin, low molecular weight heparins (LMWHs) like enoxaparin, and direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, dabigatran, and edoxaban. The choice of alternative depends on the patient's specific medical condition, risk factors, and other clinical considerations [3].
How Does Fondaparinux Sodium Injection Work?
Fondaparinux sodium injection is a synthetic pentasaccharide that selectively inhibits activated Factor X (Factor Xa) [3]. By binding to antithrombin III, it indirectly inactivates Factor Xa, which is a crucial enzyme in the coagulation cascade. This inhibition prevents the conversion of prothrombin to thrombin, thereby reducing fibrin formation and blood clot development [3].
Who Makes Fondaparinux Sodium Injection?
The original brand-name drug, Arixtra, is manufactured by Aspen Pharmacare [4]. Generic versions of Fondaparinux sodium injection are produced by various pharmaceutical companies.
What Conditions is Fondaparinux Sodium Injection Used For?
Fondaparinux sodium injection is indicated for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing hip fracture surgery, hip replacement surgery, or knee replacement surgery. It is also used for the treatment of DVT and PE in combination with warfarin [3].
Sources
1. https://www.goodrx.com/fondaparinux-sodium
2. https://drugpatentwatch.com/
3. https://www.rxlist.com/arixtra-drug.htm
4. https://www.drugs.com/manufacturer/aspen-pharmacare-1202.html